Neuroprosthesis for Paralysis
(LE-IST Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The trial tests a new device called IST-16, designed to help people with paralysis improve their ability to exercise, stand, walk, and maintain balance. The treatment involves surgically implanting a small device to stimulate muscles. This trial suits individuals with paralysis from spinal cord injuries, strokes, traumatic brain injuries, or multiple sclerosis who can move their legs and trunk muscles. Participants must be willing to undergo surgery and participate in follow-up care. As an unphased trial, this study offers the chance to contribute to groundbreaking research that could enhance mobility for those with paralysis.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this neuroprosthesis is safe for people with paralysis?
Research has shown that the IST-16 device, which aids people with paralysis through small electrical signals, appears safe. In studies, devices similar to the IST-16 have been used for over two years, with patients reporting benefits like increased physical activity and improved quality of life.
The research examined long-term use and user satisfaction, finding that these devices are generally well-tolerated. Studies have not identified any major safety issues. However, as with any surgery, risks may exist, so participants should discuss these with their doctors.12345Why are researchers excited about this trial?
Unlike traditional treatments for paralysis, which often focus on rehabilitation and physical therapy, IST-16 involves an implanted neuroprosthesis that directly interfaces with the nervous system. This innovative approach has the potential to restore movement and function by bypassing damaged neural pathways. Researchers are excited about IST-16 because it offers a new way to potentially improve mobility and independence for people with paralysis, which current methods cannot achieve. By leveraging cutting-edge technology to directly stimulate nerves, IST-16 could significantly enhance the quality of life for individuals living with paralysis.
What evidence suggests that the IST-16 system is effective for paralysis?
Research has shown that the IST-16 device, which uses electrical stimulation, can help people with paralysis move better. Studies have found that this type of stimulation strengthens muscles and aids in regaining movement. For individuals with spinal cord injuries, it has been linked to improved exercise abilities, standing, and even taking steps. Early results suggest that those with these implanted systems experience better balance and movement. Thus, the IST-16 system might enhance mobility and independence for those with paralysis.12567
Who Is on the Research Team?
Musa L Audu, Ph.D.
Principal Investigator
Louis Stokes Cleveland VA Medical Center
Ronald J Triolo, Ph.D.
Principal Investigator
Case Western Reserve University
Are You a Good Fit for This Trial?
This trial is for adults with paralysis due to spinal cord injury or conditions like stroke, who've been affected for over 6 months. They should have some intact nerve function and be able to move their joints normally. People with heart issues, pregnancy, joint contractures, severe lung/kidney/blood circulation problems, uncontrolled seizures or psychological issues, obesity, drug abuse, immune deficiencies or frequent infections can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgery and Initial Recovery
Participants undergo surgery for electrode implantation and initial recovery
Post-operative Training
Training in standing, transfers, and advanced mobility skills using the FES system
Home-based Training
Participants engage in home-based training prior to discharge for home use of the system
Follow-up
Participants are monitored for device reliability and technical performance at 6 and 12 months after discharge, and annually thereafter
What Are the Treatments Tested in This Trial?
Interventions
- IST-16
IST-16 is already approved in United States, European Union for the following indications:
- Paralysis
- Spinal Cord Injury
- Muscle Weakness
- Paralysis
- Spinal Cord Injury
- Muscle Weakness
Find a Clinic Near You
Who Is Running the Clinical Trial?
Case Western Reserve University
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
US Department of Veterans Affairs
Collaborator